199 related articles for article (PubMed ID: 27226394)
1. The configuration of the vitreomacular interface determines the pattern of pseudophakic cystoid macular oedema.
Ivastinovic D; Schwab C; Mossböck G; Weger M; Pössl SL; Petrovski G; Wedrich A; Velikay-Parel M
Acta Ophthalmol; 2017 Jun; 95(4):e347-e348. PubMed ID: 27226394
[No Abstract] [Full Text] [Related]
2. Correlations between optical coherence tomography measurement of macular thickness and visual acuity after cataract extraction--comment.
Hann JV; McKee HD
Clin Exp Ophthalmol; 2007; 35(1):105; author reply 105-6. PubMed ID: 17300588
[No Abstract] [Full Text] [Related]
3. Vitreomacular traction syndrome confused with pseudophakic cystoid macular edema.
Falcone PM
Ophthalmic Surg Lasers; 1996 May; 27(5):392-4. PubMed ID: 9156825
[TBL] [Abstract][Full Text] [Related]
4. PREOPERATIVE VITREORETINAL INTERFACE ABNORMALITIES ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY AS RISK FACTOR FOR PSEUDOPHAKIC CYSTOID MACULAR EDEMA AFTER PHACOEMULSIFICATION.
Copete S; Martí-Rodrigo P; Muñiz-Vidal R; Pastor-Idoate S; Rigo J; Figueroa MS; García-Arumí J; Zapata MA
Retina; 2019 Nov; 39(11):2225-2232. PubMed ID: 30157113
[TBL] [Abstract][Full Text] [Related]
5. Correlations between optical coherence tomography measurement of macular thickness and visual acuity after cataract extraction.
Nicholas S; Riley A; Patel H; Neveldson B; Purdie G; Wells AP
Clin Exp Ophthalmol; 2006 Mar; 34(2):124-9; quiz 194. PubMed ID: 16626425
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Campa C; Salsini G; Perri P
Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
[TBL] [Abstract][Full Text] [Related]
7. Pseudophakic Macular Edema in Primary Open-Angle Glaucoma: A Prospective Study Using Spectral-Domain Optical Coherence Tomography.
Lee KM; Lee EJ; Kim TW; Kim H
Am J Ophthalmol; 2017 Jul; 179():97-109. PubMed ID: 28499706
[TBL] [Abstract][Full Text] [Related]
8. Use of a cyclo-oxygenase 2 inhibitor for prophylaxis of cystoid macular oedema following cataract surgery: a randomized placebo-controlled trial.
Riley AF; Wakely LA; Patel HY; Neveldsen B; Purdie GL; Wells AP
Clin Exp Ophthalmol; 2006; 34(4):299-304. PubMed ID: 16764647
[TBL] [Abstract][Full Text] [Related]
9. Impact of allergy and atopy on the risk of pseudophakic cystoid macular edema.
Schaub F; Adler W; Koenig MC; Enders P; Grajewski RS; Cursiefen C; Heindl LM
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2417-2423. PubMed ID: 27553052
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography in successful surgery of vitreomacular traction syndrome.
Munuera JM; García-Layana A; Maldonado MJ; Aliseda D; Moreno-Montañés J
Arch Ophthalmol; 1998 Oct; 116(10):1388-9. PubMed ID: 9790649
[No Abstract] [Full Text] [Related]
11. Characterization of macular edema from various etiologies by optical coherence tomography.
Catier A; Tadayoni R; Paques M; Erginay A; Haouchine B; Gaudric A; Massin P
Am J Ophthalmol; 2005 Aug; 140(2):200-6. PubMed ID: 15992752
[TBL] [Abstract][Full Text] [Related]
12. [Study of vitreomacular interface in patients with pseudophakia by means of spectral optical coherence tomography].
Pomytkina NV; Sorokin EL
Vestn Oftalmol; 2016; 132(4):43-47. PubMed ID: 27600894
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac.
Sengupta S; Vasavada D; Pan U; Sindal M
Indian J Ophthalmol; 2018 Jun; 66(6):827-830. PubMed ID: 29785993
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of prognostic factors by spectral-domain optical coherence tomography in pseudophakic cystoid macular oedema].
Gallego-Pinazo R; Martínez Castillo S; Dolz-Marco R; Lleó-Pérez A; Díaz-Llopis M
Arch Soc Esp Oftalmol; 2012 Jan; 87(1):23-4. PubMed ID: 22248655
[No Abstract] [Full Text] [Related]
15. Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work?
Spitzer MS; Szurman P; Bartz-Schmidt KU
J Cataract Refract Surg; 2008 Jun; 34(6):880; author reply 880-1. PubMed ID: 18498977
[No Abstract] [Full Text] [Related]
16. Incidence of pseudophakic cystoid macular edema in eyes with and without pupil expansion device.
Taipale C; Holmström EJ; Ilveskoski L; Tuuminen R
Acta Ophthalmol; 2019 Nov; 97(7):688-694. PubMed ID: 30575287
[TBL] [Abstract][Full Text] [Related]
17. Late onset cystoid macular oedema presents a diagnostic challenge.
Nehmad L
Clin Exp Optom; 2014 Sep; 97(5):459-62. PubMed ID: 24985715
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results.
Arevalo JF; Maia M; Garcia-Amaris RA; Roca JA; Sanchez JG; Berrocal MH; Wu L;
Ophthalmology; 2009 Aug; 116(8):1481-7, 1487.e1. PubMed ID: 19545901
[TBL] [Abstract][Full Text] [Related]
19. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema.
Brar M; Yuson R; Kozak I; Mojana F; Cheng L; Bartsch DU; Oster SF; Freeman WR
Retina; 2010 Mar; 30(3):383-9. PubMed ID: 20216291
[TBL] [Abstract][Full Text] [Related]
20. Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema.
Barone A; Russo V; Prascina F; Delle Noci N
Retina; 2009 Jan; 29(1):33-7. PubMed ID: 18854783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
